The Board of Directors of the Company at its meeting held on Monday, August 17, 2026, at the Registered Office, inter alia, considered and approved: 1. Director's Report, Secretarial Audit Report and annexures for FY 2025-26; 2. Convening of the 44th AGM and draft Notice thereof; 3. Appointment of Mr. Chintan K. Patel, PCS (Mem. No. A31987, COP No. 11959), as Scrutinizer; 4. September 04, 2026 as the cut-off date for AGM voting eligibility; 5. Adoption of new MoA and AoA, subject to Members' approval; 6. Seeking Members' approval for material Related Party Transactions for FY 2026-27; 7. Enhancement of borrowing limits under Section 180(1)(c); 8. Financial transactions involving loans, guarantees or securities under Section 185; and 9. Investments, loans, guarantees or securities beyond prescribed limits under Section 186 of the Companies Act, 2013.
Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026
View original source (BSE India)Company analysis
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release Aug 12 2026
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vivanza Biosciences Ltd. Press Release Aug 08 2026
